|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
24/7 Wall St. examines Valeant Pharmaceuticals and other biotech stocks with incredible gains or losses over the course of the past week.
NEW YORK, NY / ACCESSWIRE / November 19, 2015 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Celladon Corporation (NASDAQ: CLDN) stock prior ...
Celladon (CLDN) stock is soaring on heavy trading volume on Thursday, after the company announced a merger with the privately-held Eiger BioPharmaceuticals.